Beta-amyloid increases cathepsin D levels in hippocampus

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Beta-amyloid (1-42) is retained intact by neurons in hippocampal slice cultures.
• Lysosomal dysfunction, marked by increased cathepsin D, is linked to brain aging.
• The relationship between beta-amyloid uptake and lysosomal function requires further investigation.

Purpose of the Study:

• To determine if neuronal uptake of beta-amyloid (1-42) leads to increased cathepsin D levels.
• To investigate the role of lysosomal dysfunction in the cellular response to beta-amyloid accumulation.
• To explore potential mechanisms, such as intralysosomal pH changes, underlying amyloid-induced lysosomal impairment.

Main Methods:

• Incubation of cultured hippocampal slices with beta-amyloid (1-42) peptides.
• Quantification of cathepsin D concentrations using biochemical assays.
• Assessment of interactions with cathepsin inhibitors and chloroquine to probe lysosomal pathways.

Main Results:

• Beta-amyloid (1-42) incubation significantly increased cathepsin D concentrations by 56% compared to controls.
• Scrambled peptides did not induce changes in cathepsin D levels, confirming specificity.
• The amyloid-induced cathepsin D increase showed complex interactions with cathepsin inhibitors and chloroquine, suggesting lysosomal pathway involvement.

Conclusions:

• Neuronal uptake of beta-amyloid (1-42) induces lysosomal dysfunction.
• Alterations in intralysosomal pH are implicated as a contributing factor to this amyloid-induced lysosomal impairment.
• These findings provide insights into cellular mechanisms relevant to Alzheimer's disease pathogenesis and brain aging.